GlassScriptPhysician profile
Kellyn O Chapman
NPI 1881218360
$971.72
in general payments reported to CMS, 2019-2025
14 companies · $23.02 in 2025
The $23.02 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $60.34 · 2022: $140 · 2023: $97.67 · 2024: $650 · 2025: $23.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $477 · Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $477.30 |
| Food and Beverage | $293.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $636.30 | 2024 | |
| Abbvie INC. | $84.12 | 2022-2023 | |
| Boston Scientific Corporation | $42.77 | 2023 | Wavewriter Alpha Prime 16 |
| Alvogen INC | $27.74 | 2022 | |
| Bioventus LLC | $26.34 | 2022 | |
| Stryker Corporation | $25.11 | 2021 | |
| Solventum Corporation | $23.02 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Amgen INC. | $17.74 | 2021 | |
| Spr Therapeutics, INC | $17.49 | 2021 | |
| Radius Health, INC. | $15.55 | 2022 | |
| Janssen Biotech, INC. | $14.22 | 2022 | |
| Depuy Synthes Sales INC. | $14.03 | 2024 | Monovisc, Orthovisc |
| Convatec INC. | $13.69 | 2023 | |
| Fidia Pharma USA INC. | $13.60 | 2023 | Triluron, Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellyn Chapman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.